港股異動 | 波司登(3998.HK)漲近6% 首創風衣羽絨發佈 獲券商唱好
格隆匯11月2日丨波司登(3998.HK)拉昇漲近6%,報5.92港元,暫成交8364萬港元,總市值644億港元。公司於10月27日晚在上海舉行新品大秀,正式發佈了其首創的羽絨風衣系列。東吳證券指出,公司將風衣與羽絨服相結合,功能性的羽絨服更具商務時尚,進一步提升品牌調性,拉動品牌升級。未來公司的主要增長驅動仍來自於品牌羽絨服。維持“買入”評級。有分析人士表示,風衣羽絨服的發佈,是為一個巨大、新維度的變化,再次印證其持續進化能力,無論從產業角度,或是估值角度出發,均進一步打開了其成長的“天花板”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.